1224464-97-4

Basic information

• Product Name: Methyl 6-chloro-4-Methylnicotinate
• Synonyms: Methyl 6-chloro-4-Methylnicotinate;Methyl 6-chloro-4-Methylpyridine-3-carboxylate
• CAS NO: 1224464-97-4
• Molecular Formula: C₈H₈ClNO₂
• Molecular Weight: 185.60762
• Mol File: 1224464-97-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 252.3±35.0 °C(Predicted)
• Appearance: /
• Density: 1.247±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -1.27±0.10(Predicted)
• CAS DataBase Reference: Methyl 6-chloro-4-Methylnicotinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 6-chloro-4-Methylnicotinate(1224464-97-4)
• EPA Substance Registry System: Methyl 6-chloro-4-Methylnicotinate(1224464-97-4)

Safety Data

• Hazardous Substances Data: 1224464-97-4(Hazardous Substances Data)

Usage

General Description

Methyl 6-chloro-4-Methylnicotinate is a chemical compound with the molecular formula C10H10ClNO2. It is a derivative of nicotinic acid, and it is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs. Methyl 6-chloro-4-Methylnicotinate is a chlorinated and methylated form of nicotinic acid, and it has potential applications in the treatment of various health conditions. Its properties and uses make it an important compound for research and development in the field of pharmaceuticals and drug synthesis.

Upstream product

• 1224465-02-4 5-methoxycarbonyl-4-methyl-2-hydroxypyridine 
• 67-56-1 methanol 
• 503555-50-8 6-chloro-4-methylpyridine-3-carboxylic acid 

Downstream Products

• 1430057-79-6 2-[(1S)-2-amino-1-(cyclohexylmethyl)ethyl]-6-(1-methyl-1H-pyrazol-5-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430058-98-2 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-cyclohexylpropyl]-1H-isoindole-1,3(2H)-dione 
• 1430058-71-1 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430058-70-0 6-chloro-2-[(1S)-1-(3,5-difluorobenzyl)-2-hydroxyethyl]-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430057-35-4 2-[(1S)-2-amino-1-(3-fluorobenzyl)ethyl]-6-(4-chloro-1-methyl-1H-pyrazol-5-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430058-68-6 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-(3-fluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1224464-98-5 methyl 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-4-methylnicotinate 
• 1430059-00-9 C₂₈H₂₉N₅O₃ 
• 1383816-90-7 methyl 2-(3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylate 

Relevant articles and documents

INDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.